Dr. Anna Emanuilovna Morenkova, MD

Dr. Morenkova practices at Hoag Clinic - Newport Beach in Newport Beach, California.

Dr. Morenkova's NPI, 1710204466, was assigned on April 21, 2010. Dr. Morenkova graduated from Russian State Medical University in 1995. Dr. Morenkova holds California license A123053.

Dr. Morenkova's primary practice is Hoag Clinic - Newport Beach, at 510 Superior Ave, Newport Beach, CA 92663. The practice phone is (949) 764-5700.

Dr. Morenkova's primary practice is Hoag Clinic - Newport Beach in Newport Beach, California. Dr. Morenkova is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Morenkova to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account. Dr. Morenkova's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morenkova practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Morenkova's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Morenkova is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Morenkova is licensed in California.

Dmand AI lists epilepsy, essential tremor, migraine and chronic headache, mobility impairment, neuropathy, parkinson's disease and restless legs syndrome among the conditions Dr. Morenkova treats.

CMS data shows 1,221 Medicare services from Dr. Morenkova across 10 procedure codes in 2024, for 437 Medicare patients. Medicare paid $110,120 for them. Every service was in an office.

CMS counts 437 Medicare patients who saw Dr. Morenkova in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morenkova's median patient age at 74, with 55% women.

In 2024, Dr. Morenkova wrote 4,459 Medicare Part D claims for 414 patients. 78% of them were for generic drugs. CMS names the drug for 4,288 of them, across 74 drugs with 11 or more claims each, at $2,834,034 in total drug cost. In 2023, CMS named 4,693 claims across 72 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Morenkova for performance year 2024, reported through an alternative payment model (APM). Dr. Morenkova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morenkova as offering telehealth. CMS counts 44 procedures of skin biopsy by Dr. Morenkova, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Morenkova, published from 2015 to 2024. The most frequent topics are Parkinson Disease, Deep Brain Stimulation and Robotic Surgical Procedures. Dr. Morenkova's most frequent co-authors are Neal Hermanowicz, MD, Frank Pk Hsu, MD and Nicolas M. Phielipp, MD.

Dmand AI links Dr. Morenkova to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Lewy Body Disease.

CMS Open Payments shows 25 general payments to Dr. Morenkova from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Abbvie Inc. paid the most, $3,037.

Dr. Morenkova graduated from Russian State Medical University in 1995.

Dr. Morenkova is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.